VOYA Investment Management
ALLO icon

VOYA Investment Management’s Allogene Therapeutics ALLO Stock Holding History

VOYA Investment Management’s Portfolio ALLO Stock Details ALLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$110K Buy
52,780
+26,804
+103% +$58.9K ﹤0.01% 2347
2026
Q1 		$63.4K Sell
25,976
-876
-3% -$1.76K ﹤0.01% 2252
2025
Q4 		$36.8K Hold
26,852
– – ﹤0.01% 2361
2025
Q3 		$33.3K Sell
26,852
-15,671
-37% -$18.7K ﹤0.01% 2416
2025
Q2 		$48.1K Buy
42,523
+7,926
+23% +$10.5K ﹤0.01% 2608
2025
Q1 		$50.5K Sell
34,597
-3,210
-8% -$6.05K ﹤0.01% 2549
2024
Q4 		$80.5K Buy
37,807
+436
+1% +$1.07K ﹤0.01% 2622
2024
Q3 		$105K Buy
37,371
+1,501
+4% +$4K ﹤0.01% 2652
2024
Q2 		$83.6K Buy
35,870
+4,458
+14% +$13.2K ﹤0.01% 2710
2024
Q1 		$140K Sell
31,412
-6,935
-18% -$28.9K ﹤0.01% 2550
2023
Q4 		$123K Buy
38,347
+4,851
+14% +$13.8K ﹤0.01% 2707
2023
Q3 		$106K Buy
33,496
+1,249
+4% +$5.47K ﹤0.01% 2714
2023
Q2 		$160K Sell
32,247
-144,126
-82% -$780K ﹤0.01% 2659
2023
Q1 		$871K Buy
176,373
+51,985
+42% +$333K ﹤0.01% 1732
2022
Q4 		$782K Hold
124,388
– – ﹤0.01% 1772
2022
Q3 		$1.34M Buy
124,388
+94,369
+314% +$1.28M ﹤0.01% 1481
2022
Q2 		$342K Buy
30,019
+3,409
+13% +$30.3K ﹤0.01% 2081
2022
Q1 		$242K Hold
26,610
– – ﹤0.01% 2273
2021
Q4 		$397K Buy
26,610
+19
+0.1% +$335 ﹤0.01% 2140
2021
Q3 		$683K Hold
26,591
– – ﹤0.01% 1840
2021
Q2 		$693K Buy
26,591
+2,885
+12% +$82.3K ﹤0.01% 1893
2021
Q1 		$837K Buy
23,706
+276
+1% +$9.31K ﹤0.01% 1708
2020
Q4 		$591K Buy
23,430
+5,904
+34% +$192K ﹤0.01% 1809
2020
Q3 		$661K Buy
17,526
+893
+5% +$33.7K ﹤0.01% 1506
2020
Q2 		$712K Sell
16,633
-2,953
-15% -$107K ﹤0.01% 1437
2020
Q1 		$381K Buy
19,586
+682
+4% +$16.2K ﹤0.01% 1790
2019
Q4 		$491K Buy
18,904
+4,256
+29% +$117K ﹤0.01% 1899
2019
Q3 		$399K Hold
14,648
– – ﹤0.01% 1891
2019
Q2 		$393K Buy
14,648
+6,043
+70% +$168K ﹤0.01% 1935
2019
Q1 		$249K Hold
8,605
– – ﹤0.01% 2150
2018
Q4 		$232K Buy
+8,605
New +$229K ﹤0.01% 2161

Other funds holding ALLO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
P
Pfizer New York $170M AUM 191.09% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return
SCM
Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

VOYA Investment Management's ALLO Position: Q2 2026 in Review

VOYA Investment Management increased its Allogene Therapeutics (ALLO) stake by 103% in Q2 2026, buying an estimated $58.9K and bringing the position to 52,780 shares worth $110K. The position accounts for ﹤0.01% of the portfolio, ranked #2347.

VOYA Investment Management first reported a position in ALLO in Q4 2018 and has held it in 31 quarters since. The position peaked at $1.34M in Q3 2022. 209 funds tracked by Wall St. Rank hold ALLO as of Q2 2026.

  • VOYA Investment Management held 52,780 shares of Allogene Therapeutics worth $110K as of Q2 2026.
  • VOYA Investment Management bought 26,804 Allogene Therapeutics shares in Q2 2026, an estimated $58.9K.
  • Allogene Therapeutics made up ﹤0.01% of VOYA Investment Management's portfolio in Q2 2026, its #2347 holding.
  • VOYA Investment Management first reported a position in Allogene Therapeutics in Q4 2018 and has held it in 31 quarters since.
  • VOYA Investment Management's Allogene Therapeutics position peaked at $1.34M in Q3 2022.
  • 209 funds tracked by Wall St. Rank held Allogene Therapeutics as of Q2 2026.

Based on VOYA Investment Management's 13F filing for Q2 2026, filed 12 Aug 2026.